Skip to main content

Table 1 PDXs from which TILS were obtained by culture

From: Patient-derived tumor immune microenvironments in patient-derived xenografts of lung cancer

Case ID Passages In vivo days In vitro days CD8+ (%) CD4+ (%) CD19+ (%)
1 F1 292 14 99.1 0.5 0.9
4 F1 90 10 72.1 1.6 0
5 F1 128 13 50.3 4.6 0
13 F1 98 10 76.1 20 0.7
2 F1 133 10 1.9 0 95.8
11 F1 63 10 12.3 0.2 87.1
10 F1 69 7 8.7 26.9 77.6
19 F2 84 22 99.2 0 0
16 F2 72 14 23.7 70.2 0